Fully updated and expanded, in full color with intuitive icons throughout, packed with new and expanded comparison charts, and now with patient handouts as printable PDFs - the classic reference to psychotropic medications is now more "user-friendly" than ever! The Clinical Handbook of Psychotropic Drugs has become a standard reference and practical tool for psychiatrists, psychiatric nurses, pharmacists, psychologists, physicians, and all mental health professionals. The new and fully updated 19th edition retains all the practical features for which the Clinical Handbook is renowned: - Independent, unbiased - Packed with unique comparison charts (dosages, side effects, pharmacokinetics, interactions.) that allow you to see at a glance which medication is the most suitable for each patient - Instantly recognizable icons and full color throughout, allowing you to find at a glance all the information you seek - The latest information on newly released drugs, adverse effects, approved indications (see below for details) - Succinct, bulleted information on all classes of medication: on- and off-label indications, side effects, interactions, pharmacodynamics, precautions in the young, the elderly, and pregnancy, nursing implications, and much more - all you need to know for each class of drug - Patient Handouts, Herbal and "Natural" Products, Unapproved Treatments, ECT, BLT, rTMS. New in this edition: - Pharmacotherapy for nicotine/tobacco use - Extensive revisions and additions to the antipsychotics, including dosing, adverse effects, interactions, precautions - New dosage/pharmacokinetics comparison chart for extrapyramidal agents - Extensive revisions to benzodiazepines and hypnotics/sedatives comparison chart - Updates on unapproved treatments (e.g., pregabalin and vigabatrin for alcohol and cocaine dependence) and herbal and "natural" products (e.g., for treatment of depression) - Hundreds of new references - Printable (PDF) patient handouts - Drugs with recent/changed approval include: lurasidone (Latuda), vilazodone (Viibryd), iloperidone (Fanapt), asenapine sublingual (Saphris), guanfacine (Tenex, Intuniv), degarelix (Firmagon), finasteride (Proscar) - Preparations added include: Symbyax, Prozac Weekly, Luvox CR, Aplenzin, Oleptro, Silenor, Zonolon, Invega Sustenna, Zyprexa Relprevv, Mellaril, Compoz, Epitol, Teril, Nytol, Simply Sleep, Sominex, Unisom, clonidine SR (Kapvay)
Auflage
19., 19th revised and expanded ed.
Sprache
Verlagsort
Zielgruppe
Für Beruf und Forschung
Psychiatrists, psychiatric nurses, pharmacists, clinical psychologists, other mental health professionals
Editions-Typ
Illustrationen
+ 50 pp. printable PDF patient information sheets
Maße
Höhe: 280 mm
Breite: 216 mm
ISBN-13
978-0-88937-395-2 (9780889373952)
Schweitzer Klassifikation
Antidepressants
Selective Serotonin Reuptake Inhibitors (SSRI) Norepinephrine Dopamine Reuptake Inhibitor (NDRI) Serotonin Norepinephrine Reuptake Inhibitor (SNRI) Serotonin-2 Antagonists/Reuptake Inhibitors (SARI) Noradrenergic/Specific Serotonergic Antidepressants (NaSSA) Non-Selective Cyclic Antidepressants Monoamine Oxidase Inhibitors Reversible Inhibitor of MAO-A (RIMA) Irreversible Monoamine Oxidase Inhibitors Monoamine Oxidase B Inhibitor Effects of Antidepressants on Neurotransmitters/ Receptors Pharmacological Effects of Antidepressants on Neurotransmitters/Receptors Frequency of Adverse Reactions to Cyclic Antidepressants at Therapeutic Doses Frequency (%) of Adverse Reactions to MAOI Antidepressants at Therapeutic Doses Antidepressant Doses and Pharmacokinetics Switching Antidepressants Antidepressant Augmentation Strategies
Electroconvulsive Therapy (ECT)
Bright-Light Therapy (BLT)
Repetitive Transcranial Magnetic Stimulation (rTMS)
Antipsychotics
"Second-Generation" Antipsychotics/SGAs "Third-Generation" Antipsychotic/TGA "First Generation" Antipsychotics/FGAs Effects of Antipsychotics on Neurotransmitters/Receptors Pharmacological Effects of Antipsychotics on Neurotransmitters/ Receptors Frequency (%) of Adverse Reactions to Antipsychotics at Therapeutic Doses Antipsychotic Doses and Pharmacokinetics (Oral and Short-Acting Injections) Comparison of Long-acting IM Antipsychotics Extrapyramidal Adverse Effects of Antipsychotics Switching Antipsychotics Antipsychotic Augmentation Strategies
Agents for Treating Extrapyramidal Side Effects
Effects on Extrapyramidal Symptoms Comparison of Agents for Treating Extrapyramidal Side Effects Doses and Pharmacokinetics of Agents for Treating Extrapyramidal Side Effects
Anxiolytic (Antianxiety) Agents
Benzodiazepines Comparison of the Benzodiazepines Buspirone
Hypnotics/Sedatives
L-Tryptophan Comparison of Hypnotics/Sedatives
Mood Stabilizers
Lithium Anticonvulsants Comparison of Anticonvulsants Comparison of Adverse Reactions to Mood Stabilizers at Therapeutic Doses
Drugs for ADHD
Psychostimulants Atomoxetine Comparison of Drugs for ADHD Alpha-2 Agonists Augmentation Strategies in ADHD
Drugs for Treatment of Dementia
Cholinesterase Inhibitors Memantine Comparison of Drugs for Treatment of Dementia
Sex-Drive Depressants
Comparison of Sex-Drive Depressants
Drugs of Abuse
Alcohol Stimulants Hallucinogens Opiates/Narcotics Inhalants/Aerosols Gamma-hydroxy Butyrate (GHB)/Sodium Oxybate Flunitrazepam (Rohypnol) Nicotine/Tobacco
Treatment of Substance Use Disorders
Disulfiram Acamprosate Naltrexone Methadone Buprenorphine Pharmacotherapy for Nicotine/Tobacco Use Dependence
Unapproved Treatments of Psychiatric Disorders
Adrenergic Agents Dopaminergic Agents GABA-Agents/Anticonvulsants Serotonin Antagonists Hormones Miscellaneous
Herbal and "Natural" Products
Glossary
Patient Information Sheets
Index of Drugs
